Is your organization missing from this list? Reach out to Danielle Cann, Strategic Alliance Partnership Coordinator, to learn more about the complimentary strategic partnership program: dcann@mjhlifesciences.com
Tivozanib Combo Yields Similar PROs to Monotherapy in Advanced Clear Cell RCC
Dose Reductions Possible for Tivozanib With and Without Nivolumab for RCC
Nivolumab Combo for RCC Necessitates AE Monitoring, Awareness
Proactive Onco-Coaching Linked to Higher OS in mRCC